×
The $7 target used here is not an analyst consensus ; VATE has effectively no current, multi-analyst coverage, so the objective is drawn from a technical milestone rather than a published price forecast. At a recent price near $5.27, reaching $7 would require a gain of roughly 33%, a substantial move for this low-float, volatile holding company.
The $44 objective used here is the top of the current analyst price target range and sits just above the stock's 52-week high of $43.14 — not the consensus mean. The latest verified price is about $37.75, so reaching $44 would require roughly 16.6% upside — a substantial move.
Tetra Tech closed fiscal 2026 with record fourth-quarter earnings per share (EPS) of $0.51 and adjusted EPS of $0.49, up 9% year over year. Fourth-quarter revenue totaled $1.34 billion, with net revenue of $1.15 billion as the company continued its "Leading with Science" water and environment focus.
LGN shares climbed from a previous close of $32.05 to $34.59, up +7.93%, during regular market hours. No verified news or fundamental catalyst found — the rise is consistent with a technical rebound ahead of the company's Q3 earnings (due Nov 12), after shares collapsed from about $39 to a $25.41 low this month on data-center policy fears following the midterm elections.
PHOE jumped +8.81% during regular-session trading, rising from a previous close of $15.89 to $17.29. No verified news or fundamental catalyst found. The move is consistent with speculative micro-cap trading in a thin order book, with the stock's typical daily swing averaging roughly ±4%.
ITG fell sharply during regular trading hours, sliding from a previous close of $5.34 to $4.40, a -17.60% decline. The drop followed ITG's Q3 2026 results (released after the Nov. 10 close) and its Nov. 11 earnings call: revenue rose roughly +49% year over year and beat guidance, but the company still posted a $6.15 million net loss attributable to shareholders while cash dwindled to about $160,000, extending its post-IPO slide.
The $15 central target is the arithmetic mean of eight verified analyst price targets reviewed for ITG , rounded from a calculated mean of roughly $14.63. Shares recently traded near $5.30, meaning the stock would need to rise roughly 180% to reach $15 — a very large move.
LGN edged up from a $32.16 prior close to $32.76, a +1.87% gain, during regular trading hours. No verified news or fundamental catalyst found; the move is likely a modest extension of the rebound from the post-election data-center selloff, with the stock consolidating ahead of its November 12 earnings report.
Cadeler (CDLR) dropped from a previous close of $7.16 to $6.75, a -5.73% decline, during regular market hours. No verified news or fundamental catalyst found — the slide is consistent with continued post-redomiciliation volatility after the Nov 5 voluntary share exchange repriced the ADR from roughly $25.84 to $7.40, with the stock swinging -9% and +6% in the sessions since.
Backlog visibility: A record backlog exceeding $5 billion, up double digits year over year, provides revenue visibility into 2027 across diversified end markets. Upcoming catalysts: Fourth-quarter and full-year 2026 results, expected around February 2027, plus initial 2027 guidance will be pivotal for sentiment.
The central $55 target is the arithmetic mean of roughly nine current analyst price targets, which range from $50 to $60. With APG trading near $45, reaching $55 would require a move of roughly 20%–22%.
APi Group (APG) trades around $42–$43 per share, up roughly 5% over the trailing 30 days and positioned within its 52-week range of $34.02 to $49.99. Third-quarter 2026 results, reported on October 29, beat expectations with adjusted EPS of $0.50 versus a $0.47 consensus and record revenue of approximately $2.55 billion, up 22.5% year over year.
The central target used here is $40 , the arithmetic mean of roughly a dozen verified analyst price targets rounded to a clean figure. The underlying average sits near $40–$41, with an approximate range of $26 to $62 — an unusually wide spread that reflects genuine disagreement on valuation.
Revenue rose 10% year over year to $580.3 million, topping the consensus estimate of roughly $572.9 million. Non-GAAP earnings per share (EPS) came in at $0.88, beating the analyst consensus of $0.57 by $0.31.
ITG, Inc. (ITG) jumped +12.88% during regular trading hours, climbing from a previous close of $4.58 to $5.17. No verified news or fundamental catalyst found. The move is consistent with a rebound after a sharp multi-week slide and speculative positioning ahead of the company's third-quarter earnings report due after Tuesday's close.
The central $15 price target is the arithmetic mean of nine verified analyst price targets collected from individual firm reports, not a published official consensus. The current verified price of roughly $4.58 implies about 227% upside to $15, a very large move by any standard measure.
The central target of $645 is the arithmetic mean of six current analyst price targets issued or refreshed between mid-October and early November 2026. The shares recently traded near $252.82 , meaning the target requires a rise of approximately 155% — a very large move.
Sterling Infrastructure (STRL) declined roughly 43.7% over the trailing 30 days, falling from a $513.00 close on October 9 to about $288.67 in November 9 intraday trading. The steepest single-day drop followed a Texas gubernatorial election result that raised the prospect of new restrictions on data center construction in the state.
ACM is AECOM, a global infrastructure consulting leader with an approximately $8.5 billion market capitalization, while CCM is Concord Medical Services Holdings, a China-based oncology healthcare provider with a market capitalization under roughly $25 million. The two companies operate in entirely different sectors and risk profiles, making this a study in contrasts between a diversified infrastructure franchise and a small-cap, single-market healthcare operator.
The central $68 stock price target is the average of verified analyst price targets that sit above the latest share price, not a published consensus figure. The stock last traded near $58.71, meaning a move to $68 would require a roughly 15.8% gain — a substantial advance.